4//SEC Filing
Schoeps Megan 4
Accession 0001600132-17-000134
CIK 0001600132other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:36 PM ET
Size
6.7 KB
Accession
0001600132-17-000134
Insider Transaction Report
Form 4
Schoeps Megan
Principal Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-12-13$0.49/sh+1,000$490→ 19,248 total - Exercise/Conversion
Stock Option (right to buy)
2017-12-13−1,000→ 3,000 totalExercise: $0.49Exp: 2026-12-07→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the underlying shares on each one year anniversary of the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001700789
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:36 PM ET
- Size
- 6.7 KB